What are Vasopressin analog drugs?

Vasopressin analog drugs are pharmacologic agents that share a common mechanism (typically targeting Vasopressin V1 receptor). 2 are currently marketed, with 2 more in clinical development.

What are the marketed Vasopressin analog drugs?

Marketed Vasopressin analog drugs include terlipressin (vasoconstrictor), Terlipressin & then Dummy.

Vasopressin analog

2 marketed 2 in Phase 3

This page covers all Vasopressin analog drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Vasopressin V1 receptor, V2 receptor (vasopressin receptor 2).

Targets

Vasopressin V1 receptor · V2 receptor (vasopressin receptor 2)

Marketed (2)

terlipressin (vasoconstrictor) · National Science and Technology Council, Taiwan · Gastroenterology / Hepatology
Terlipressin is a vasopressin analog that selectively activates V1 receptors on vascular smooth muscle to cause vasoconstriction and reduce portal pressure.
Terlipressin & then Dummy · Aga Khan University · Gastroenterology / Hepatology
Terlipressin is a vasopressin analog that selectively activates V1 receptors on vascular smooth muscle to cause vasoconstriction and reduce portal pressure.

Phase 3 pipeline (2)

Terlipressin administration · University Hospital, Rouen · Gastroenterology / Hepatology
Terlipressin is a vasopressin analog that selectively activates V1 receptors on vascular smooth muscle to cause vasoconstriction and reduce portal pressure.
Desmopressin Injectable Solution · Hamilton Health Sciences Corporation · Endocrinology
Desmopressin is a synthetic vasopressin analog that binds to V2 receptors on kidney collecting duct cells to increase water reabsorption and reduce urine output.